The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

Evan Seigerman, BMO head of healthcare research, joins 'Power Lunch' to discuss Seigerman's thoughts on Novo Nordisk, its ...

Body of missing 9-year-old California girl Melodee Buzzard found, mother arrested Georgia official responds to 315,000 ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...

Novo Nordisk shares jumped nearly 8% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, ...

As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Novo Nordisk A/S is rated a Buy with improved execution and valuation gap with LLY to drive outperformance through 2026. Read ...

Hyderabad: Global pharma heavyweights Eli Lilly and Novo Nordisk are racing to lock in market leadership in India’s blooming ...

In a milestone development Monday, the Food and Drug Administration green-lit an oral version of the obesity treatment Wegovy ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...